Success Metrics

Clinical Success Rate
85.7%

Based on 6 completed trials

Completion Rate
86%(6/7)
Active Trials
8(42%)
Results Posted
0%(0 trials)
Terminated
1(5%)

Phase Distribution

Ph phase_3
1
5%
Ph not_applicable
8
42%
Ph phase_2
2
11%

Phase Distribution

0

Early Stage

2

Mid Stage

1

Late Stage

Phase Distribution11 total trials
Phase 2Efficacy & side effects
2(18.2%)
Phase 3Large-scale testing
1(9.1%)
N/ANon-phased studies
8(72.7%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

85.7%

6 of 7 finished

Non-Completion Rate

14.3%

1 ended early

Currently Active

8

trials recruiting

Total Trials

19

all time

Status Distribution
Active(10)
Completed(6)
Terminated(1)
Other(2)

Detailed Status

Recruiting8
Completed6
Not yet recruiting2
Suspended1
Terminated1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
19
Active
8
Success Rate
85.7%
Most Advanced
Phase 3

Trials by Phase

Phase 22 (18.2%)
Phase 31 (9.1%)
N/A8 (72.7%)

Trials by Status

not_yet_recruiting211%
suspended15%
recruiting842%
completed632%
terminated15%
unknown15%

Recent Activity

Clinical Trials (19)

Showing 19 of 19 trials
NCT05702645

A Study to Learn More About the Health of Persons With Down Syndrome After Treatment for Acute Leukemia

Recruiting
NCT04804644Phase 3

Testing if High Dose Radiation Only to the Sites of Brain Cancer Compared to Whole Brain Radiation That Avoids the Hippocampus is Better at Preventing Loss of Memory and Thinking Ability

Recruiting
NCT07331077Not Applicable

A Physical Activity Program Compared to Health Education for Improving Memory and Attention in Hispanic Women With Newly-Diagnosed Stage I-IIIa Breast Cancer, MAMA Trial

Not Yet Recruiting
NCT04771806

Serial Advanced Magnetic Resonance Imaging Scan for Guidance of Personalized Adaptive Radiotherapy for High Grade Glioma

Recruiting
NCT06315296Not Applicable

An Interactive Time-Restricted Diet Intervention (txt4fasting) for Reducing Neurocognitive Decline and Improving Survival in Patients With Brain Metastases From Breast or Lung Cancer

Terminated
NCT07439302Not Applicable

Monitoring of Neurological Symptoms, Treatment Tolerance, and Quality of Life Using the Resilience PRO Electronic Patient-reported Outcome Application in Patients With IDH-mutated Glioma

Not Yet Recruiting
NCT04343573Phase 2

Proton Craniospinal Radiation Therapy vs. Partial Photon Radiation Therapy for Leptomeningeal Metastasis From Solid Tumors

Completed
NCT05428852Not Applicable

Keto-Brain:Investigating the Use of Ketogenic Diets in Brain Metastases

Suspended
NCT05011045

Neurocognitive Outcomes After Whole Brain Radiation Therapy for Hematologic Malignancies

Recruiting
NCT07160153

Cannabis Abstinence and Neurocognitive Assessment in Adolescence

Recruiting
NCT06377696Phase 2

Remote Cognitive Assessment and Wearable Device While Assessing the Impact of Metformin in Patients With History of Cranial Radiation Therapy

Recruiting
NCT06439355Not Applicable

Single-center Study of Gustation in Idiopathic Parkinson's Disease and Lewy Body Disease Using Gustatory Evoked Potential Analysis

Recruiting
NCT03187652

A Prospective Study on the Long-Term Vascular Burden in Thrombotic Thrombocytopenic Purpura Patients

Recruiting
NCT04785157

Neurotropism and Neuroinflammation in COVID-19 Patients With Delirium.

Completed
NCT04593069Not Applicable

The COGCOV Study in ICU Patients

Completed
NCT04135365

Pediatric Type 1 Diabetes and Neurocognitive Complications Cohort Study

Completed
NCT02592174Not Applicable

Prevalence, Characteristics and Risk Factors of HIV-Associated Neurocognitive Disorders in Subjects Between the Ages of 55 and 70 Years: An Exposed/Unexposed Cross Sectional Study

Completed
NCT02339649Not Applicable

Long-term Cognitive and Cerebral Changes in Sepsis Survivors and Their Predictors

Unknown
NCT00533884

Neurocognitive Functioning in Patients With Newly Diagnosed Upper Aerodigestive Tract Cancer Receiving Treatment at Henry-Joyce Cancer Clinic

Completed

All 19 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
19